Conviction upgraded MEDIUM-HIGH → HIGH on cell mfg + L&T validationCMP: ₹174 | Horizon: 3 Years
CMP₹174
FY26 PAT (Actual)₹307 Cr ✓
Order Book₹11,338 Cr
L&T First Order250 MWh ★
Container Realization$82–84/kWh
Cell Cost$48–50/kWh
BOO IRR (MSEDCL)12–13%
Cell Mfg AnnouncementImminent ★
P/E FY27E~16x
★
V4 KEY ADDITIONS FROM OFFICIAL CONCALL TRANSCRIPT (June 3, 2026 BSE Filing):
(1) Cell manufacturing announcement imminent — CMD stated "very much on the cards, coming soon"; transforms moat from assembler to manufacturer. (2) L&T 250 MWh order (Jan 2026) — first external commercial customer; L&T previously bought from China. (3) Precise BESS unit economics: $82–84/kWh realization, $48–50/kWh cell cost (60–65% of system). (4) Receivables 4-bucket decomposition: ₹1,125 Cr near-term, ₹900 Cr unbilled (3–5yr), ₹295 Cr BSNL deferred, ₹122 Cr retention. (5) BOO unit economics confirmed: ₹93L/MWh net cost, ₹2.19L/MW/month revenue, 12–13% SPV IRR. (6) Net debtor/creditor = ₹650 Cr — actual WC exposure far lower than gross. (7) LFP cell prices +20% from April 2026 — near-term margin risk quantified. (8) Data centre as new growth vertical.
Updated Investment Thesis — v4
The official Q4 FY26 concall transcript (BSE filing June 3, 2026) delivers three thesis-altering disclosures that materially strengthen the bull case: (1) Cell manufacturing is imminent — an announcement is coming that would transform Lineage Power from an LFP assembler to a vertically integrated cell manufacturer, the most consequential moat expansion possible in BESS; (2) L&T has become the first external commercial customer — India's largest engineering conglomerate, previously buying from China, has awarded 250 MWh to Lineage Power after a formal evaluation process; (3) The BOO economics are now fully transparent — ₹93L/MWh net cost, ₹2.19L/MW/month government annuity, 12–13% SPV IRR — confirming the model works. The receivables picture is more nuanced than prior reports: only ~₹1,125 Cr is near-term Q4 billing (normalizing by Sep'26), while ~₹1,320 Cr is structural (unbilled milestones over 3–5 years + BSNL deferred + retention). Net debtor/creditor exposure is only ₹650 Cr. At ₹174 with management-guided FY27–FY28 revenue of ₹3,200–4,200 Cr, cell manufacturing optionality unpriced, and L&T institutional validation confirmed, we upgrade conviction to HIGH.
◎
V4 New Findings — From Official Concall Transcript
June 3, 2026 BSE Filing
★ NEW
Cell Manufacturing
Imminent
CMD: "Very much on the cards. Announcement coming soon." Transforms moat.
★ NEW
L&T First External Order
250 MWh
Jan 2026. Prev. bought from China. Passed formal evaluation. ~₹175 Cr revenue.
NEW
BESS Container Realization
$82–84/kWh
Cell cost: $48–50/kWh (60–65% of system). Gross margin ~$33–36/kWh (~40%)
⚠ NEW RISK
China Cell Price Spike
+20%
From April 2026 (rebate cut 9%→6%). Q1 FY27 protected by inventory. Q2+ at risk.
★ HIGHEST CONVICTION NEW FINDING — Cell Manufacturing Announcement Imminent
"As you know, we are already in a leading position in cell to pack and pack to container manufacturing in India. Cell manufacturing is very much on the cards. We will be coming up soon with an announcement." — CMD Venugopal Rao
— Q4 FY26 Earnings Conference Call, May 26, 2026 | Official Transcript filed BSE June 3, 2026 | Ref: PDL/2026-27/Q01_34
⚡ WHY CELL MANUFACTURING IS THE MOST IMPORTANT CATALYST IN THE THESIS
Current state: Lineage Power buys LFP cells from China at $48–50/kWh, which represents 60–65% of the entire BESS system cost. Every time China changes export rebates (already cut from 9% to 6%, +20% price impact) or geopolitical tensions flare, margins are directly exposed.
Post-announcement: In-house cell manufacturing eliminates this dominant cost variable. Gross margin per system expands from ~40% to potentially 55–65%. The strategic moat deepens from "assembler" to "integrated manufacturer" — a categorically different valuation multiple.
Capex implications: Cell gigafactories cost ₹500–2,000+ Cr per GWh — significant investment. Management has NOT disclosed timeline or capex quantum. This remains optionality, not guidance. But the CMD's explicit language ("coming soon with an announcement") signals this is imminent-stage, not conceptual.
Valuation impact: At 10 GWh capacity, domestic cell manufacturing could reduce cost by ~₹400–500 Cr annually at full utilization. Even at 50% probability weight, this justifies a meaningful P/E re-rating — potentially moving Pace from ~16x to 20–22x forward earnings.
★ NEW — L&T as First External Commercial Customer (250 MWh, Jan 2026)
"Our first customer other than our own internal consumption is L&T. Earlier L&T was buying from China. They have awarded us an order of 250 MWh in January after completing their evaluation and validation process. The BESS business is a complete ecosystem — it involves PCS and EMS as well. We are supplying a solution, not just a product. We have around 200 engineers supporting field operations." — CMD Venugopal Rao
— Q4 FY26 Earnings Conference Call, May 26, 2026 | Official Transcript
L&T ORDER — STRATEGIC SIGNIFICANCE
Import Substitution Validated: L&T, with the most rigorous procurement standards in India's engineering sector, previously sourced BESS from China. The switch to Lineage Power validates product quality at institutional-commercial grade.
Revenue is Fully Reported: This is a direct third-party external sale by Lineage Power — not subject to consolidation elimination. 250 MWh at ~₹70L/MWh = ~₹175 Cr fully appearing in consolidated P&L.
Pipeline Opens: L&T has an enormous BESS project pipeline across India. A validated supplier relationship with L&T creates a recurring commercial channel at scale, entirely separate from government PSU orders.
01
BESS Manufacturing — Precise Unit Economics (Concall-Derived)
60–65% of total system value. Source: China. Subject to export rebate policy. Already +20% since Apr 2026. Strategic inventory provides Q1 FY27 protection.
Non-Cell Components
~$33–36/kWh
PCS (Power Conversion System), EMS, container, BMS, integration, labour. In-house container fab (Jul '26) saves ~4–5% on this component. Margin upside as localization improves.
Container Realization
$82–84/kWh
Current market price for containerized BESS system. Gross margin implied: ~$32–36/kWh (~39–43%). Cell mfg announcement would expand this to potentially 55–65% gross margin.
BESS COST WATERFALL ($/kWh)
CHINA REBATE IMPACT ON CELL COST (Scenario Analysis)
⚠ NEW RISK — China LFP Cell Price +20% from April 2026
"From 1st April the rates have increased due to regulatory changes — the rates have increased by almost 20%. The inventory built up as of 31st March has helped us during the current quarter. But subsequently, we expect prices to moderate. For all our bidding, we have kept some contingency factors for all these rate increase scenarios, which will take care of our margin protection." — CFO Rajavendhan P
— Q4 FY26 Concall | China export rebate cut from 9% → 6%, set to expire in next year
CELL PRICE RISK — MARGIN IMPACT MODELLING
Scenario
Cell Cost $/kWh
% of System
System Realization
Gross Margin $
Gross Margin %
EBITDA Impact
Base (pre-Apr'26)
$40/kWh
~48%
$83/kWh
$43/kWh
~52%
Reference
Current (Apr'26 post-rebate)
$48–50/kWh
~60%
$83/kWh
$33–35/kWh
~40–42%
-1,000 bps
Bear (rebate fully removed)
$55–58/kWh
~67–70%
$83/kWh
$25–28/kWh
~30–34%
-1,800 bps
Bull (cell mfg in-house)
$28–32/kWh
~34–39%
$83/kWh
$51–55/kWh
~61–66%
+2,000 bps
Note: EBITDA margin at system level. Consolidated margin is lower due to EPC mix, employee costs, and BOO accounting treatment. Strategic inventory protects Q1 FY27. Q2 FY27 is the first quarter of full China price exposure.
02
BOO Platform — Full Unit Economics (MSEDCL Live Example)
New Section — CFO Disclosed
Gross Project Cost
₹1.32 Cr/MWh
Includes GST of ₹0.20 Cr/MWh
Net Cost (post-GST, post-VGF)
₹93L/MWh
After ₹0.27 Cr/MWh VGF grant. Net equity/debt requirement.
Government Annuity
₹2.19L/MW/month
Revenue paid per installed MW capacity. SPV IRR: 12–13%
MSEDCL BOO PROJECT — LIVE UNIT ECONOMICS MODEL (CFO-Disclosed, Q4 FY26 Concall)
Cost Structure (per MWh)
₹/MWh
Note
Gross Project Cost
₹1.32–1.35 Cr
Including GST
Less: GST
(₹0.20 Cr)
Recoverable
Net Cost
₹1.20 Cr
Pre-VGF
Less: VGF Grant
(₹0.27 Cr)
Govt. support
Net Equity+Debt Requirement
₹93 L/MWh
The actual investment
Revenue Stream
Govt. Payment Rate
₹2.19L/MW/month
For MSEDCL
MSEDCL Project (1.02 GWh = 510 MW)
₹134 Cr/year
Annual annuity
SPV Level IRR
12–13%
After EPC cost to parent
BOO DUAL PROFIT POOL — HOW PACE CAPTURES VALUE
Pool 1 — Parent (Pace Digitek)
EPC contract awarded to Pace Digitek by the SPV at arm's length market rate. Pace books EPC margin (8–10%) on the full project value. This appears in consolidated P&L.
Pool 2 — SPV (TransGreenX)
SPV owns the asset and receives government annuity. IRR 12–13% at SPV level. Revenue recognized under Ind AS dealer-lessor model (standalone BESS) or energy sale model (solar+BESS).
Total effective IRR to Pace group (EPC margin + SPV IRR) significantly exceeds the 12–13% SPV-level number. CMD's earlier hint of 19–20% effective IRR is consistent with this two-pool structure.
📞 BOO Accounting — Important for Revenue Modelling
"For standalone BESS projects, we follow the dealer-lessor model under Ind AS — revenue and the related receivable are recognized upfront. For solar plus BESS projects, we use fixed asset accounting — no construction revenue; instead revenue comes from energy sales over the concession period. For BOO standalone: 1.5–2 year execution. Solar+BESS BOO: 2–3 years. MSEDCL (1.02 GWh) + KPTCL (0.50 GWh) = 1.52 GWh follow lease model. SECI Solar+BESS (0.10 GWh) + KREDL Solar+BESS (1.10 GWh) = 1.20 GWh follow fixed asset model — no construction revenue recognized." — CFO Rajavendhan P
— Q4 FY26 Concall | This means FY27 BOO revenue guidance of ₹800–1,000 Cr comes primarily from MSEDCL lease income
03
Receivables — Definitive 4-Bucket Analysis
Revised — More Nuanced Than v3
⚠ Analyst Note — Receivables Are More Structurally Entrenched Than v3 Suggested
The concall reveals that of the ₹2,442 Cr total receivables, only ~₹1,125 Cr is the near-term Q4 billing overhang normalizing by Sep'26. The remaining ~₹1,320 Cr is structural — comprising ₹900 Cr of unbilled milestone receivables (3–5 year billing timeline), ₹295 Cr of BSNL 5-year deferred collections, and ₹122 Cr of retention. Total receivables will NOT return to historical levels in the near term. However, the net debtor/creditor position is only ₹650 Cr — creditors have grown proportionally, acting as a natural hedge.
Bucket 1 — Q4 Billing Spike
~₹1,125 Cr
Normalizing Sep'26
Q4 FY26 revenue of ₹1,097 Cr at 90–120 day cycle. ₹300 Cr already collected Apr–May 2026. Remaining ~₹825 Cr expected by Sep'26. Management has committed to even quarterly distribution in FY27.
Bucket 2 — Unbilled Milestones
~₹900 Cr
3–5 Year Billing
"Milestone-based outstanding yet to be billed — ₹900 crores over next 3–5 years." ~₹150–175 Cr per year. This is unbilled revenue (not yet invoiced), not a collection risk. Will appear as revenue as milestones are achieved.
Bucket 3 — BSNL 5-Yr Deferred
~₹295 Cr
5-Year Collection
Classified as non-current trade receivable. Contractual 5-year payment schedule. ~₹59 Cr/year cash collection. Permanent structural absorption — will not normalize. Already known and embedded in project economics.
Bucket 4 — Retention Money
~₹122 Cr
Post-Commissioning
~5% of total receivables. Standard industry practice — released after project completion and defect liability period. Low risk, time-bound collection tied to commissioning timelines.
NET WORKING CAPITAL — THE KEY METRIC (CFO Guidance)
NET DEBTOR/CREDITOR POSITION
₹650 Cr
Gross receivables ₹2,442 Cr minus creditors (which have also grown 77% YoY). CFO: "Net of debtors and creditors is about ₹650 crores with a 90-day cycle — that is the relevant metric." Extended payable terms match the receivable cycle structurally.
REVISED RECEIVABLES NORMALISATION OUTLOOK
Sep'26 (guided): Bucket 1 normalizes — ~₹825 Cr collected FY27–FY29: Bucket 2 converts to revenue as milestones hit (~₹175 Cr/yr) 5-Year (BSNL): Bucket 3 collects ~₹59 Cr/year Post-commissioning: Bucket 4 releases as projects complete
178 BESS containers delivered FY26 — no other Indian company has achieved this
480 MWh executed in utility-scale projects
First commissioned project: September 2025 — operational for 1+ year
L&T 250 MWh: first external commercial customer validated
Network Operating Centre (NOC) managing all projects remotely
⚙ In Progress — Expansion
+2.5 GWh
Target: July 2026 | Equipment at factory, installation underway
Machinery from China received; 2-month delay due to West Asia shipping disruptions — now resolved
"Will be commissioned within June itself and become operational from July"
Container fabrication plant also operational July 2026
Container fab savings: 4–5% pricing/operating efficiency + 30% overhead elimination
Total capacity post-July: 5 GWh
🔧 Under Construction — New Facility
+5 GWh
Target: October 2026 | Construction complete, machinery ordered
"We have completed necessary infrastructure and plant construction. Orders placed for 5 GWh production lines — operational October 2026"
"Ahead of our earlier plans" — originally sequential, now parallel build
10 GWh at ~80% utilization = 8 GWh annual output by Mar'27
Enables C&I entry: Maharashtra/Gujarat/Rajasthan mandatory BESS policies for 50MW+ solar
Cell manufacturing announcement expected before this comes online
CAPACITY RAMP & UTILIZATION (GWh)
REVENUE POTENTIAL AT SCALE (₹ Crore — External Product Sales)
05
Competitive Moat — Why Pace Maintains Lead
Concall-Reinforced
📞 CMD on Competitive Advantage — Right to Win
"The BESS business is a complete ecosystem and not just manufacturing. If somebody puts up a plant, it does not mean they will automatically get the business. In the private business, customers look at manufacturing capabilities, field operations, support availability in India, and technical knowledge and know-how. Our first project was commissioned in September last year — products have been working in the field for more than a year. We have built a Network Operating Centre and are monitoring all plants remotely. We have around 200 engineers who are supporting field operations. BESS order book is the largest in the country among individual companies today."
— CMD Venugopal Rao, Q4 FY26 Concall
MOAT ASSESSMENT — CONCALL-UPDATED
Moat Dimension
Evidence from Concall
Strength
Direction
Manufacturing Scale (10 GWh Oct'26)
"Largest individual company BESS order book in India"
Strong
↑ Strengthening
Field Operations (200 engineers)
NOC remote monitoring; 1+ year track record in field
Strong
↑ Unique in India
Cell Manufacturing (Imminent)
"Very much on the cards — announcement coming soon"
Optionality
↑ Game changer if executed
Customer Validation (L&T)
L&T switched from China after formal evaluation
Strong
↑ New
Technology Neutrality
"Technology-immune — buy cells as input, adopt best tech"
Moderate
→ Neutral
Cell Sourcing Risk
60–65% cell cost from China; +20% price spike Apr'26
BOO: 20–25% of topline (₹800–1,000 Cr). MSEDCL first project: ₹1,000 Cr annuity potential FY27. NEC XON Africa: 300–500 MWh.
FY28E Guidance
₹4,000–4,200 Cr
+21–27% YoY | Positive OCF
10 GWh at 80% util. BOO adds ~₹1,000 Cr more. Cell mfg optionality. C&I entry. Data centre solutions.
FY28 Revenue Conservative?
Possibly
CFO acknowledged analyst point
"Your observation is correct. Quite possible that we will achieve this or even exceed it." Analyst's bull case: 5 GWh at ₹1,200 Cr/GWh = ₹6,000 Cr from BESS alone.
NEW — MD confirmed "coming soon". Margin uplift 1,500–2,000 bps if in-house
Data Centre Solutions
Early-stage
FY28+ revenue
—
₹100 Cr
NEW — AI data centres seeking RTC green energy
Less: Net Debt
—
₹192 Cr net
—
(₹200 Cr)
0.09x net D/E; comfortable
Total Equity Value
—
—
—
₹8,640 Cr
—
Per Share (21.7 Cr shares)
—
—
—
~₹398
Full SOTP — bull scenario ceiling
Valuation note: At a conservative 20x FY27E PAT, the core business trades at a meaningful discount to peers. The cell manufacturing announcement (imminent per CMD) is the key re-rating catalyst — if confirmed before or during FY27, it would materially improve the fundamental value estimate. Management guidance is acknowledged as potentially conservative by the CFO.
Bear Case
₹120–130
Probability: 10% (↓ from 15%)
China cell prices stay elevated; margins fall below 13% EBITDA
Cell mfg commissioned FY28 — margin explosion to 55%+ gross
FY28 revenue exceeds ₹4,500 Cr (analyst bull case confirmed)
L&T pipeline drives 500+ MWh commercial orders
Data centre BESS solutions scale in H2 FY28
Institutional coverage initiates — re-rating to 22–25x
09
Key Monitorables — v4 Updated
2 Confirmed | 3 New | 1 Upgraded
01
Cell Manufacturing Announcement — The #1 Catalyst
CMD explicitly stated "very much on the cards — coming soon with an announcement." This is the single most important event in the Pace Digitek thesis over the next 6–12 months. Track BSE Reg 30 exchange filings for JV/partnership/greenfield announcement. Key questions on announcement: (a) in-house vs. JV, (b) capex quantum and funding plan, (c) timeline to first cell production, (d) whether it triggers equity dilution. Even a JV announcement with a credible partner would be a significant positive re-rating event.
★ Top Priority
02
5 GWh Commissioning — July 2026 Exchange Filing
"Equipment is already in our factory and under installation. It will be commissioned within June itself and become operational from July." Track: (a) exchange filing confirming commissioning, (b) first production milestone from new line, (c) whether L&T 250 MWh order is being fulfilled from new capacity. July 2026 is the next hard-date catalyst after this report.
₹300 Cr collected Apr–May 2026 confirmed. Remaining ~₹825 Cr of Q4 billing overhang expected by Sep'26. Track: Q1 FY27 results (Aug 2026) for trade receivables trajectory. Note: total receivables will NOT return to sub-₹1,000 Cr historically — revised floor is ₹1,200–1,500 Cr due to structural components (₹900 Cr unbilled milestones, ₹295 Cr BSNL deferred). Stop signal: receivables above ₹2,200 Cr in Q2 FY27 results.
Sep'26 Checkpoint
04
China Cell Price Trajectory — Q2 FY27 First Exposure Quarter
NEW: LFP cell prices at $48–50/kWh post China rebate cut (+20% from April 2026). Strategic inventory protects Q1 FY27 margins. Q2 FY27 (Jul–Sep 2026) results will be the first quarter showing full cell price impact. Management expects moderation; has embedded contingency in project bids. Track: any further China policy change on export rebates; LFP spot prices (currently $0.048–0.050/Wh). If prices fall back to $38–42/kWh by Q2, margin impact is contained.
Q2 FY27 Margin Watch
05
Energy Business Leadership — Replacement Appointment
Business Head Energy Sunil Jayam (effective May 30, 2026). Not addressed in official concall transcript — management avoided the topic. Energy segment drove 90% of FY26 order inflows. Monitor: Q1 FY27 energy order inflow pace (must maintain ₹1,000+ Cr quarterly run-rate vs. FY26's ₹5,815 Cr annual). Any announcement of replacement via exchange filing or press release is a positive signal.
Open — Urgent
06
L&T Commercial Pipeline — Follow-on Orders
NEW: L&T's 250 MWh order (Jan 2026) is a relationship-opener, not a one-off. L&T has among the largest private BESS project pipeline in India as a developer. Track: any follow-on order disclosure from L&T or similar tier-1 private sector players. The "private sector customers" category in the order book detail will be the leading indicator.
Finance Lease Receivables of ₹568 Cr on FY26 balance sheet confirm BOO revenue has commenced. MSEDCL is the primary driver (lease model — upfront revenue recognition). Track Q1 FY27 and Q2 FY27 BOO revenue line — management guided ₹1,000 Cr from MSEDCL in FY27. Note: SECI Solar+BESS and KREDL Solar+BESS use fixed asset model — no construction revenue, only future energy sale revenue.
✅ Live — Track Growth
08
Gross Debt Trajectory — Max ₹1,500 Cr Without BOO Annuity Offset
Gross debt at ₹961 Cr vs. ₹161 Cr a year ago. Management: no further BOO beyond first 3 projects (funded via IPO/accruals) + 1 external-funded project without external investment. Watch: if new BOO projects are announced before cell mfg capex plan, this signals inconsistency with stated capital discipline. Net D/E at 0.09x is healthy — gross debt is the metric to watch.
Watch
10
Risk Matrix — Updated with Concall New Data
Business Risks
Energy Leadership Gap. Sunil Jayam effective May 30 — not mentioned in concall transcript. Energy drove 90% of FY26 order inflows. Replacement caliber and Q1 FY27 order momentum are the two key signals. Most urgent unresolved risk.High
China Cell Price Risk (+20% from Apr'26). NEW: LFP cells at $48–50/kWh post rebate cut. Q1 FY27 protected by strategic inventory. Q2 FY27 is first exposed quarter. Management has embedded contingency in project bids. If prices stay elevated, EBITDA margin could compress 200–300 bps below guidance.High — New
Cell Manufacturing Execution Risk. CMD has signaled an imminent announcement. If in-house cell manufacturing is attempted and delayed/cost-overruns, it could be a significant negative — cell gigafactories are complex, capital-intensive, and technically challenging. The risk of announcing without delivering is real.Medium — New
Competition Intensifying. "Many players have announced capacity for BESS assembly." CMD acknowledges L1 bidding for govt projects is competitive. Pace's moat is field operations + NOC + 18-month track record + L&T validation — not price. Private market preserves premium.Medium ↓
Financial Risks — Revised
Receivables Floor Higher Than Expected. Total receivables will NOT normalize to historical levels. Structural floor ~₹1,200–1,500 Cr (₹900 Cr unbilled milestones + ₹295 Cr BSNL deferred + ₹122 Cr retention). Net debtor/creditor = ₹650 Cr is the true exposure measure.Medium — Revised
OCF Positive Only in FY28. CFO confirmed. FY27 OCF will improve but Q4 billing evenness + new project ramp may keep it marginal. Structural BOO annuity is the fix — ₹134 Cr/yr from MSEDCL alone is cash (lease receipts), improving OCF quality in H2 FY27.Medium ↓
Cell Manufacturing Capex. If the imminent announcement involves significant capex (₹500–2,000 Cr per GWh), this would require equity raise or further debt. Dilution risk and leverage risk need modelling once quantum is disclosed.Medium — New
Positive New Developments
L&T Validation (250 MWh). India's most rigorous procurement organization has switched from China to Lineage. Creates recurring pipeline access and institutional credibility signal to other tier-1 private developers.Positive
BOO Unit Economics Transparent. Full cost structure now disclosed. ₹93L/MWh net cost, ₹2.19L/MW/month annuity, 12–13% SPV IRR. No ambiguity about the economics — they work, and the dual profit pool (EPC margin + SPV annuity) creates compelling total returns.Positive
FY28 Guidance May Be Conservative. CFO acknowledged analyst's point that 5 GWh utilization at ₹1,200 Cr/GWh = ₹6,000 Cr from BESS alone, before telecom and BOO. "Quite possible we achieve or exceed it." Asymmetric upside to guidance.Positive
Regulatory & Macro
China Export Rebate Policy. Rebate already cut from 9% to 6% and "set to expire next year." Full removal = another 6% cell cost increase = additional margin pressure. Force majeure provisions exist for project timeline extensions per management.High — Watch
State BESS Policy Rollout (Positive). Maharashtra, Gujarat, Rajasthan mandating BESS for 50MW+ solar installations. Creates C&I BESS demand entirely separate from central govt tenders. Pace already has products and certifications in progress for C&I segment.Positive
Data Centre Green Energy Demand. AI data centres seeking 24x7 renewable power. Pace teams actively developing RTC energy solutions. Not a FY27 revenue item but positions the company at the intersection of BESS + AI infrastructure.Long-Term Positive
Thesis Summary — v4 Update
Three new primary-source disclosures materially strengthen the thesis: (1) The CMD's explicit statement that cell manufacturing is "very much on the cards — announcement coming soon" is the most consequential optionality disclosure. In-house cells would eliminate the largest cost input, transforming gross margins from ~40% to ~60%+; (2) L&T's 250 MWh order (previously bought from China) provides institutional-grade commercial validation — if India's largest engineering firm trusts Lineage over Chinese suppliers, the product is de-risked; (3) Full BOO unit economics disclosed — ₹93L/MWh net cost, ₹2.19L/MW/month annuity, 12–13% IRR — confirm the model works. The two remaining risks (Energy Head vacancy; China cell prices) are execution and commodity risks, not structural thesis risks.
Key Catalysts & Risks to Monitor
↑ THESIS STRENGTHENERS:
Cell manufacturing announcement with credible partner/timeline
Follow-on L&T order or other tier-1 private sector win
5 GWh commissioning confirmed via exchange filing (July '26)
Q1 FY27 margins confirm China cell price contingency is holding
Energy Head replacement with strong energy sector background
NEC XON first Africa order placed and disclosed
↓ THESIS WEAKENERS:
China cell prices rise further — rebate fully removed
Q1 FY27 energy order inflows below ₹800 Cr (vs. ₹1,450 Cr quarterly run-rate)
5 GWh commissioning slips beyond Q2 FY27
Gross debt crosses ₹1,500 Cr without BOO annuity acceleration
CRISIL downgrade or governance red flag
Report Version: 4.0 | Date: June 3, 2026 | Price at Analysis: ₹174 | Shares Outstanding: 21.7 Cr
Primary Sources (v4 — All Primary): Official Q4 & FY26 Earnings Call Transcript (BSE Filing Ref: PDL/2026-27/Q01_34, June 3, 2026) · Q4 & FY26 Investor Presentation (Ref: PDL/2026-27/Q01_27, May 26, 2026) · CRISIL Rating Rationale A-/Stable (Apr 1, 2026) · BSE/NSE BESS Milestone Filing (Apr 10, 2026) · Order Inflow Filing (Apr 16, 2026) · NEC XON OEM Agreement (Apr 23, 2026) · Prior analysis versions v1–v3 (Apr–May 2026).
For institutional and sophisticated investor reference only. Cell manufacturing disclosure is CMD intent, not confirmed plan — timeline and capex not yet disclosed. China cell price risk is a live, unquantified margin headwind for Q2 FY27+. This does not constitute investment advice. Investors must conduct independent due diligence before making investment decisions.
Pace Digitek company story
Not investment advice. This is independent research for informational purposes only. Investors must conduct their own due diligence before making investment decisions.